Compound 1812
Identifiers
- Canonical SMILES:
Cc1noc(C)c1-c1ccccc1
- IUPAC name:
3,5-dimethyl-4-phenyl-1,2-oxazole
- InChi:
InChI=1S/C11H11NO/c1-8-11(9(2)13-12-8)10-6-4-3-5-7-10/h3-7H,1-2H3
- InChiKey:
BHAXDAUULXCVEK-UHFFFAOYSA-N
External links
![]() 5325760 |
![]() CHEMBL1828979 |
A9P |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
3 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 4.46 | breast cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 173.08 g/mol | |||
HBA | 2 | |||
HBD | 0 | |||
HBA + HBD | 2 | |||
AlogP | 2.32 | |||
TPSA | 26.03 | |||
RB | 1 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 3 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1021/jm200640v | 3a | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen BRD4 | pIC50 (half maximal inhibitory concentration, -log10) | 4.07 | |
10.1021/jm200640v | 3a | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen BRD2 | pIC50 (half maximal inhibitory concentration, -log10) | 4.46 | |
10.1021/jm200640v | 3a | CBP Q92793 |
H4 P62805 |
Biochemical assay | alphascreen CREBBP | pIC50 (half maximal inhibitory concentration, -log10) | 3.70 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7000 | Valdecoxib | DB00580 | |
0.5691 | Parecoxib | DB08439 | |
0.4248 | Isocarboxazid | DB01247 | |
0.4192 | Alobresib | DB14970 | |
0.3977 | 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE | DB06964 | |
0.3867 | AUY922 | DB11881 | |
0.3821 | 3-phenyl-5-(1H-pyrazol-3-yl)isoxazole | DB07613 | |
0.3770 | Leflunomide | DB01097 | |
0.3763 | 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide | DB06961 | |
0.3738 | 3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL | DB07236 | |
0.3487 | 2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL | DB08715 | |
0.3450 | 5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID | DB08001 | |
0.3444 | Muscimol | DB12458 | |
0.3416 | 6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE | DB07202 | |
0.3410 | PX-102 | DB15416 |